Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Oxidopamine MeSH Descriptor Data 2025


MeSH Heading
Oxidopamine
Tree Number(s)
D02.092.311.342.478.650
D02.455.426.559.389.657.166.175.342.478.650
Unique ID
D016627
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016627
Scope Note
A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
Entry Term(s)
6-Hydroxydopamine
6-OHDA
Oxidopamine Hydrobromide
Oxidopamine Hydrochloride
Pharm Action
Sympatholytics
Adrenergic Agents
Registry Numbers
8HW4YBZ748
28094-15-7
636-00-0
Related Numbers
1199-18-4
28094-15-7
636-00-0
CAS Type 1 Name
1,2,4-Benzenetriol, 5-(2-aminoethyl)-
Previous Indexing
Hydroxydopamines (1973-1991)
Public MeSH Note
92; 6-HYDROXYDOPAMINE was indexed under HYDROXYDOPAMINES 1982-91 & under HYDROXYDOPAMINE 1981
Online Note
use OXIDOPAMINE (NM) to search 6-HYDROXYDOPAMINE (NM) 1980-91
History Note
92; was 6-HYDROXYDOPAMINE (NM) 1981-91
Date Established
1992/01/01
Date of Entry
1991/07/12
Revision Date
2018/07/02
Oxidopamine Preferred
Oxidopamine Hydrochloride Narrower
Oxidopamine Hydrobromide Narrower
page delivered in 0.12s